2 - Network organisation and process
|
Quality
Management |
Training and
Education |
Public
Involvement |
| Description | ||
|---|---|---|
Name |
Newcastle-CCLG - Newcastle Children's Cancer and Leukaemia Pharmacology Studies Group |
|
| Existence of an identified contact person for external enquiries | Yes | |
| Existence of an internal steering committee | No | |
| Existence of an external advisory steering committee directing the reporting party | Yes | Data integrity and conduct of studies are monitored by Cancer Research UK, the wider CCLG professional body and an independent Data Safety and Ethics Monitoring Committee for specific clinical trials. |
| Existence of a website | Yes | https://cclg.arithmostech.com/ |
| Existence of newsletter | Yes | An annual newsletter is published and made available through the group's website and via email. In addition, study specific newsletters are also published. |
| Existence of internal databases for disease, condition treatment and/or outcome | Yes | Database containing pharmacokinetic, pharmacodynamic and pharmacogenetic data. |
| Provisions to ascertain data protection and data security | Yes | Governed by UK National Health Service data protection regulations, the data protection act 1998 and the declaration of Helsinki. |
| Procedures to access the database by third parties | No | |
| Access to external databases/registries | Yes | Access to patient databases through the CCLG tissue bank and through the Birmingham clinical trials unit (CR-CTU). |
| Standardised process to access an external database | Yes |